Orexin Receptor Targets for Anti-Relapse Medication Development in Drug Addiction.
about
Orexin antagonists for neuropsychiatric disease: progress and potential pitfallsPrefrontal Cortical Opioids and Dysregulated Motivation: A Network Hypothesis.Feeding-modulatory effects of mu-opioids in the medial prefrontal cortex: a review of recent findings and comparison to opioid actions in the nucleus accumbens.
P2860
Orexin Receptor Targets for Anti-Relapse Medication Development in Drug Addiction.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on June 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Orexin Receptor Targets for Anti-Relapse Medication Development in Drug Addiction.
@en
Orexin Receptor Targets for Anti-Relapse Medication Development in Drug Addiction.
@nl
type
label
Orexin Receptor Targets for Anti-Relapse Medication Development in Drug Addiction.
@en
Orexin Receptor Targets for Anti-Relapse Medication Development in Drug Addiction.
@nl
prefLabel
Orexin Receptor Targets for Anti-Relapse Medication Development in Drug Addiction.
@en
Orexin Receptor Targets for Anti-Relapse Medication Development in Drug Addiction.
@nl
P2093
P2860
P356
P1433
P1476
Orexin Receptor Targets for Anti-Relapse Medication Development in Drug Addiction.
@en
P2093
Ronald E See
Wei-Lun Sun
P2860
P304
P356
10.3390/PH4060804
P577
2011-06-01T00:00:00Z